Early identification of severe immune checkpoint inhibitor associated myocarditis: From an electrocardiographic perspective

Documenti analoghi

• Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study
  di: Yi Zheng, et al.
  Pubblicazione: (2024)
• Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
  di: Yuan Meng, et al.
  Pubblicazione: (2024)
• Analysis of the clinical efficacy and safety of anti‐PD‐1 immune checkpoint inhibitors in locally advanced nasopharyngeal cancer
  di: Shuling Shi, et al.
  Pubblicazione: (2024)
• Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor
  di: Guiming Deng, et al.
  Pubblicazione: (2024)
• Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
  di: Haiqing Zhao, et al.
  Pubblicazione: (2024)